Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... represent the first tool permitting stable transduction of leukemic cancer cells, B-cell chronic lymphocytic leukemia cells, blocked in G(0)/G(1) early phase of the cell cycle. Thus, H/F-LV transduction ...
2009 NOV 9 ... U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow. Arzerra is ...
2009 NOV 2 ... a phase 3 trial of Campath's use in combination with Fludara in relapsed or refractory chronic lymphocytic leukemia patients, which recently met its primary endpoint. There will be presentations on ...
2009 NOV 9 ... LIGHT, or HVEM mAb, thus far known to costimulate T- and B-cell activation, induced chronic lymphocytic leukemia cell death. Many of the mediators involved were identified here, with an apoptotic ...
2009 NOV 23 ... important new results in indications such as multiple myeloma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia and myelodysplastic syndromes. Keywords: , Health, ...
2009 NOV 9 ... to recent research from London, the United Kingdom, "Stem cell transplantation in chronic lymphocytic leukemia (CLL) is an evolving field." "Younger patients with high-risk disease ...
2009 NOV 23 ... publish new data in the report 'BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.' "A number of single nucleotide polymorphisms (SNP) have been implicated to impact ...
2009 NOV 2 ... we detected the surface expression of CD79b in almost all non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia patients, suggesting that anti-CD79b-vcMMAE could be widely used in these ...
2009 NOV 9 ... were BTLA+ and follicular dendritic cells were HVEM+. BTLA was strongly expressed in chronic lymphocytic leukemia/ small lymphocytic lymphoma (B-CLL/SLL, 17 of 17 positive) when compared with other ...
2009 NOV 2 ... weakly expressed. Blood group genotyping is useful for patients with conditions such as chronic lymphocytic leukemia, autoimmune hemolytic anemia and Hodgkin's lymphoma, in which red blood cells are ...
2009 NOV 2 ... a subset of the marginal zone B cells. They also showed MNDA expression in subgroups of chronic lymphocytic leukemia, mantle-cell lymphoma, and diffuse large B-cell lymphoma, but MNDA was especially ...
2009 NOV 23 ... 3 most common subtypes: diffuse large B-cell lymphoma, follicular lymphoma, and B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Height was positively associated with risk of all B-cell ...
2009 NOV 2 ... and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia,' is newly published data in Leukemia. "Thalidomide represents a promising ...
2009 NOV 23 ... regulation and, if deregulated, in the development of neoplastic disorders including chronic lymphocytic leukemia (CLL). RNAs from primary cells of 50 treatment-naive CLL patients and peripheral B cells ...
2009 NOV 9 ... According to a study from the United States, "Though B-chronic lymphocytic leukemia (CLL) is known to be a heterogeneous disease, only recently has the familial component ...
2009 NOV 9 ... According to recent research from the United States, "With chronic lymphocytic leukemia (CLL) with high-risk cytogenetic features such as del(17p13) have limited treatment ...
2009 NOV 2 ... in 'Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia' new findings in chronic lymphocytic leukemia. ...
2009 NOV 23 ... positive data from 1) an ongoing Phase 1 clinical trial of TRU-016 for the treatment of chronic lymphocytic leukemia (CLL), and 2) a preclinical study demonstrating the effect of Trubion's ...
2009 NOV 16 ... advance our clinical programs, including TRU-015 for rheumatoid arthritis, TRU-016 for chronic lymphocytic leukemia and SBI-087 for rheumatoid arthritis and systemic lupus erythematosus," said Peter ...
